FILE:HCP/HCP-8K-20110822200200.txt.gz
EVENTS:	Regulation FD Disclosure	Financial Statements and Exhibits
TEXT:
ITEM: Regulation FD Disclosure
ITEM: Financial Statements and Exhibits
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
           
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
           
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
           
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
           
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
Item 7.01
                                            
Regulation FD Disclosure.
 
On August 22, 2011, HCP, Inc. (the "Company"), a Maryland corporation, issued a press release, attached as Exhibit 99.1 hereto, announcing that the Company will promptlypay the approximately $102 million judgment against the Company resulting from the 2009 jury verdict awarding compensatory damages to Ventas, Inc.  The Company accrued the full amount of the $102 million compensatory award during the third quarter of 2009, and accordingly the Company's payment will have no additional impact on the Company's earnings.
 
The information set forth in this Item 7.01 of this Current Report on Form 8-K, and in Exhibit 99.1 hereto, is being furnished to, and shall not be deemed filed with, the Securities and Exchange Commission ("SEC") nor shall such information be deemed incorporated by reference in any filing with the SEC under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.
 
Item 9.01
                                       
Financial Statements and Exhibits.
 
(d)           Exhibits.  The following exhibit is being filed herewith:
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
Dated:    August 22, 2011
 
 

Exhibit 99.1
 
 
HCP TO PAY JUDGMENT IN VENTAS LITIGATION
 
LONG BEACH, CA  August 22, 2011  HCP (NYSE:HCP) announced that it will promptly pay the approximately $102 million judgment against the Company resulting from the 2009 jury verdict awarding compensatory damages to Ventas, Inc.  The Company accrued the full amount of the $102 million compensatory award during the third quarter of 2009, and accordingly the Company's payment will have no additional impact on the Company's earnings.
 
About HCP
 
HCP, Inc., an S&P 500 company, is a real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States.  HCP has been a publicly traded NYSE listed company since 1985.  Our portfolio of properties is distributed among distinct sectors of healthcare including: senior housing, life science, medical office, post-acute/skilled nursing and hospital. 
For more information, visit us at www.hcpi.com.
 
Contact
 
HCP
Timothy M. Schoen
Executive Vice President and Chief Financial Officer
(562) 733-5309
 


